Sunfield Clinic withdraws plan to start adipose-derived stem-cell treatment

The cells derived from adipose-derived stem cells were intended to target hardening of the arteries and diabetes. Five consecutive reviews by MHLW evaluation committees came to the conclusion that the experimental plans required further modifications, and the Clinic finally decided to opt out.

Nikkei Biotech, June 6, 2016

Sunfield Clinic withdraws plan to start adipose-derived stem-cell treatment
Scroll to top